| Type of Endocrine Disorder | Examples |
| A) Hyperfunction | |
| 1. Neoplastic | |
| Benign | Pituitary adenomas, hyperparathyroidism, autonomous thyroid or adrenal nodules, pheochromocytoma |
| Malignant | Adrenal cancer, medullary thyroid cancer, carcinoid |
| Ectopic | Ectopic ACTH, SIADH secretion |
| Multiple endocrine neoplasia | MEN 1, MEN 2 |
| 2. Autoimmune | Graves' disease |
| 3. Iatrogenic | Cushing's syndrome, hypoglycemia |
| 4.Infectious/inflammatory | Subacute thyroiditis
|
| 5. Activating receptor mutations | LH, TSH, Ca2+ and PTH receptors, Gs-alpha
|
| B) Hypofunction | |
| Autoimmune | Hashimoto's thyroiditis, Type 1 diabetes mellitus, Addison's disease, polyglandular failure |
| Iatrogenic | Radiation-induced hypopituitarism, hypothyroidism, surgical |
| Infectious/inflammatory | Adrenal insufficiency, hypothalamic sarcoidosis |
| Hormone mutations | GH, LH, FSH, vasopressin |
| Enzyme defects | 21-Hydroxylase deficiency |
| Developmental defects | Kallmann syndrome, Turner syndrome, transcription factors |
| Nutritional/vitamin deficiency | Vitamin D deficiency, iodine deficiency |
| Hemorrhage/infarction | Sheehan's syndrome, adrenal insufficiency
|
| C) Hormone resistance | |
| Receptor mutations | |
| Membrane | GH, vasopressin, LH, FSH, ACTH, GnRH, GHRH, PTH, leptin, Ca2+ |
| Nuclear | AR, TR, VDR, ER, GR, PPAR-alpha |
| Signaling pathway mutations | Albright's hereditary osteodystrophy |
| Postreceptor | Type 2 diabetes mellitus, leptin resistance |
|
No comments:
Post a Comment